(Q47964620)

7 February 2018

title

Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse (English)

1 reference

7 February 2018

0 references

Gayo A

1

1 reference

7 February 2018

Mozo L

2

1 reference

7 February 2018

Suárez A

3

1 reference

7 February 2018

Tuñon A

4

1 reference

7 February 2018

Lahoz C

5

1 reference

7 February 2018

Gutiérrez C

6

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

number of pages

9

1 reference

Journal of Neuroimmunology

inferred from page(s)

published in

1 reference

7 February 2018

volume

85

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

122-130

1 reference

7 February 2018

Interleukin-10 regulation in normal subjects and patients with asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Megadose corticosteroids in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Quantitative PCR: theoretical considerations with practical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900262-2

7 January 2021

10.1016/S0165-5728(97)00262-2

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018